查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1776821

迷走神经刺激市场：全球产业分析、规模、份额、成长、趋势与预测，2025-2032

Vagus Nerve Stimulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 200 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球迷走神经刺激 (VNS) 市场的全面分析报告。该报告对关键市场动态进行了全面评估，包括市场驱动因素、趋势、机会和挑战，并对市场结构提供了详细的洞察。

关键见解

  • 迷走神经刺激市场规模（2025年）：5.423亿美元
  • 市场规模预测（以金额为准，2032 年）：10.134 亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：9.3%

迷走神经刺激市场-分析范围

迷走神经刺激是一种神经调节技术，用于治疗多种神经和精神疾病，包括癫痫、抗治疗性忧郁症、偏头痛，以及近期出现的发炎和自体免疫疾病。迷走神经刺激 (VNS) 市场为医院、神经科诊所、门诊手术中心和居家医疗机构提供植入式和非侵入式迷走神经刺激 (VNS) 设备。神经系统疾病盛行率的上升、人们对生物电子医学的兴趣日益浓厚，以及支持迷走神经刺激新型治疗应用的临床研究的不断扩展，推动了迷走神经刺激市场的成长。

市场成长动力：

全球迷走神经刺激市场的发展受到神经和精神疾病替代疗法日益增长的需求的推动。癫痫和抗治疗性忧郁症的发生率不断上升，尤其是在高龄化社会中，这促使人们将迷走神经刺激（VNS）作为一种安全有效的干预措施。越来越多的美国食品药物管理局（FDA）核准，以及越来越多的临床试验探索VNS在偏头痛、纤维肌痛甚至发炎性肠道疾病肠道疾病等疾病中的应用，正在扩大这种治疗方法的范围。微型植入式系统、体外刺激器和人工智慧VNS设备等技术进步，透过提高治疗精准度和患者便利性，进一步刺激了市场扩张。

市场限制：

儘管迷走神经刺激 (VNS) 临床前景广阔，但由于设备成本高且报销范围有限，市场面临许多製约，尤其是在新兴经济体。手术植入迷走神经刺激系统 (VNS) 有手术风险和术后併发症，这给患者和医护人员带来了不确定性。监管挑战以及对迷走神经刺激 (VNS) 新用途进行广泛临床检验的需求，可能会延迟其市场准入并增加研发支出。此外，患者和全科医生对迷走神经刺激 (VNS) 作为治疗方法的认知度较低，限制了其广泛应用。

市场机会：

迷走神经刺激 (VNS) 市场拥有良好的成长潜力，这得益于非侵入式迷走神经刺激 (VNS) 设备的开发，这些设备可以消除手术风险并降低治疗成本。其在精神病学和免疫学领域的应用扩展，例如创伤后压力症候群 (PTSD)、焦虑类风湿性关节炎和克隆氏症，将带来重要的新收益来源。与数位健康平台（例如行动控制的迷走神经刺激设备和远端监控系统）的集成，可以提高患者的参与度和治疗效果。医疗技术公司与学术研究机构之间的策略伙伴关係预计将加速生物电子医疗领域的创新和商业化。

本报告回答的关键问题

  • 影响迷走神经刺激市场全球成长的关键驱动因素有哪些？
  • 哪些设备类型和治疗应用正在塑造 VNS 未来应用？
  • 神经调节和穿戴式装置的创新如何改变 VNS 市场格局？
  • 迷走神经刺激市场的主要企业有哪些？他们正在采取哪些策略倡议？
  • 全球 VNS 生态系中存在哪些新兴趋势和尚未开发的机会？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长预测
  • COVID-19影响分析
  • 预测因子：相关性和影响力

第三章 加值分析

  • 产品采用分析
  • 监管状况
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章 价格分析（2024年）

  • 主要亮点
  • 影响产品价格的关键因素
  • 按产品进行价格分析
  • 区域价格和产品偏好

第五章全球迷走神经刺激市场展望

  • 主要亮点
    • 市场规模预测（以数量为基础）
    • 市场规模及年成长率（以金额为准）
    • 绝对的商机
  • 市场规模分析与预测（以金额为准）
    • 历史市场规模分析（以金额为准，2019-2024）
    • 市场规模分析与预测（以金额为准，2025-2032）
  • 全球迷走神经刺激市场（按产品）展望
    • 引言/主要发现
    • 历史市场规模分析：按产品（价值和数量，2019-2024）
    • 按产品分類的市场规模分析和预测（价值和数量基础，2025-2032 年）
      • 植入式神经刺激装置
      • 外接式、非侵入性迷走神经刺激装置
    • 市场吸引力分析：按产品
  • 全球迷走神经刺激市场应用前景
    • 引言/主要发现
    • 按应用分類的历史市场规模分析（以金额为准，2019-2024）
    • 按应用分類的市场规模分析和预测（以金额为准，2025-2032）
      • 癫痫
      • 忧郁症
      • 偏头痛
      • 其他的
    • 市场吸引力分析：按应用
  • 全球迷走神经刺激市场前景（按最终用户）
    • 引言/主要发现
    • 按最终用户分類的历史市场规模分析（以金额为准，2019-2024 年）
    • 最终用户的市场规模分析与预测（以金额为准，2025-2032）
      • 医院
      • 专科诊所
      • 门诊手术中心
      • 学术研究机构
      • 其他的
    • 最终用户的市场吸引力分析

6. 全球迷走神经刺激市场（按地区）展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（以金额为准，2019-2024 年）
  • 各地区市场规模分析及预测（以金额为准，2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

7. 北美迷走神经刺激市场展望

8. 欧洲迷走神经刺激市场展望

第九章东亚迷走神经刺激市场展望

10.南亚与大洋洲迷走神经刺激市场展望

11.拉丁美洲迷走神经刺激市场展望

12.中东与非洲迷走神经刺激市场展望

第十三章竞争格局

  • 市场占有率分析（2024年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争对手仪表板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Soterix Medical Inc.
    • LivaNova PLC
    • SetPoint Medical
    • Vagutism
    • tVNS Technologies GmbH
    • electroCore, Inc.
    • Adriakaim, Inc.
    • MicroTransponder Inc.
    • Parasym, Ltd.
    • Pulsetto
    • Teliatry, Inc.
    • biolitec（R）Holding GmbH &Co KG
    • AURIMOD GMBH
    • Evren Technologies, Inc.
    • NeurGear
    • Hoolest
    • Neuvana
    • BioSelf Technology Ltd.

第十四章 附录

  • 分析方法
  • 分析假设
  • 首字母缩写和简称
简介目录
Product Code: PMRREP34750

Persistence Market Research has recently released a comprehensive report on the worldwide market for vagus nerve stimulation (VNS). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Vagus Nerve Stimulation Market Size (2025E): USD 542.3 Mn
  • Projected Market Value (2032F): USD 1,013.4 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Vagus Nerve Stimulation Market - Report Scope:

Vagus nerve stimulation is a neuromodulation technique used to treat various neurological and psychiatric disorders, including epilepsy, treatment-resistant depression, migraine, and more recently, inflammatory and autoimmune conditions. The VNS market serves hospitals, neurological clinics, ambulatory surgical centers, and homecare settings, offering both implantable and non-invasive VNS devices. Growth is driven by the rising prevalence of neurological conditions, growing interest in bioelectronic medicine, and expanding clinical research supporting new therapeutic applications of vagus nerve stimulation.

Market Growth Drivers:

The global vagus nerve stimulation market is driven by a growing demand for alternative therapies for neurological and psychiatric disorders. Rising rates of epilepsy and treatment-resistant depression-particularly in aging populations-are fueling adoption of VNS as a safe and effective intervention. Increasing FDA approvals and clinical trials exploring VNS applications in conditions like migraine, fibromyalgia, and even inflammatory bowel disease are expanding the therapy's reach. Technological advances such as miniaturized implantable systems, external wearable stimulators, and AI-enabled VNS devices further stimulate market expansion by enhancing treatment precision and patient convenience.

Market Restraints:

Despite its clinical promise, the VNS market faces limitations due to high device costs and limited reimbursement coverage, especially in developing economies. Surgical implantation of VNS systems involves procedural risks and postoperative complications, creating apprehension among patients and healthcare providers. Regulatory challenges and the need for extensive clinical validation for emerging applications of VNS can slow market entry and increase R\&D expenditures. In addition, low awareness among patients and general practitioners about VNS as a treatment modality limits its widespread adoption.

Market Opportunities:

The VNS market holds promising growth potential through the development of non-invasive VNS devices, which eliminate surgical risks and lower treatment costs. Expansion into psychiatric and immunological applications, such as PTSD, anxiety disorders, rheumatoid arthritis, and Crohn's disease, presents significant new revenue streams. Integration with digital health platforms, such as mobile-controlled VNS devices and remote monitoring systems, improves patient engagement and outcomes. Strategic partnerships between medtech firms and academic research institutions are expected to accelerate innovation and commercialization in the bioelectronic medicine space.

Key Questions Answered in the Report:

  • What are the primary drivers influencing the global growth of the vagus nerve stimulation market?
  • Which device types and therapeutic applications are shaping the future of VNS adoption?
  • How are innovations in neuromodulation and wearable devices transforming the VNS market landscape?
  • Who are the leading players in the vagus nerve stimulation market and what strategic initiatives are they pursuing?
  • What emerging trends and untapped opportunities exist in the global VNS ecosystem?

Competitive Intelligence and Business Strategy:

These firms are investing in next-generation non-invasive VNS systems and exploring applications in mental health and autoimmune diseases. Collaborations with neurology departments, regulatory bodies, and digital health startups are enhancing their market positioning. Additionally, efforts to improve device affordability and expand insurance coverage are helping these players reach underserved markets.

Key Companies Profiled:

  • Soterix Medical Inc.
  • LivaNova PLC
  • SetPoint Medical
  • Vagutism
  • tVNS Technologies GmbH
  • electroCore, Inc.
  • Adriakaim, Inc.
  • MicroTransponder Inc.
  • Parasym, Ltd.
  • Pulsetto
  • Teliatry, Inc.
  • biolitec(R) Holding GmbH & Co KG
  • AURIMOD GMBH
  • Evren Technologies, Inc.
  • NeurGear
  • Hoolest
  • Neuvana
  • BioSelf Technology Ltd.

Vagus Nerve Stimulation Market Research Segmentation:

By Product:

  • Implantable VNS Device
  • External Non-invasive VNS Device

By Application:

  • Epilepsy
  • Depression
  • Migraine
  • Others

By End-user:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Academic & Research Institutes
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vagus Nerve Stimulation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Vagus Nerve Stimulation Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Vagus Nerve Stimulation Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Implantable VNS Device
      • 5.3.3.2. External Non-invasive VNS Device
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Vagus Nerve Stimulation Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Epilepsy
      • 5.4.3.2. Depression
      • 5.4.3.3. Migraine
      • 5.4.3.4. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Vagus Nerve Stimulation Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Specialty Clinics
      • 5.5.3.3. Ambulatory Surgical Centers
      • 5.5.3.4. Academic & Research Institutes
      • 5.5.3.5. Others
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Vagus Nerve Stimulation Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Vagus Nerve Stimulation Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Implantable VNS Device
    • 7.4.2. External Non-invasive VNS Device
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Epilepsy
    • 7.5.2. Depression
    • 7.5.3. Migraine
    • 7.5.4. Others
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Centers
    • 7.6.4. Academic & Research Institutes
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Vagus Nerve Stimulation Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Implantable VNS Device
    • 8.4.2. External Non-invasive VNS Device
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Epilepsy
    • 8.5.2. Depression
    • 8.5.3. Migraine
    • 8.5.4. Others
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Centers
    • 8.6.4. Academic & Research Institutes
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Vagus Nerve Stimulation Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Implantable VNS Device
    • 9.4.2. External Non-invasive VNS Device
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Epilepsy
    • 9.5.2. Depression
    • 9.5.3. Migraine
    • 9.5.4. Others
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Centers
    • 9.6.4. Academic & Research Institutes
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Implantable VNS Device
    • 10.4.2. External Non-invasive VNS Device
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Epilepsy
    • 10.5.2. Depression
    • 10.5.3. Migraine
    • 10.5.4. Others
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Centers
    • 10.6.4. Academic & Research Institutes
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Vagus Nerve Stimulation Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Implantable VNS Device
    • 11.4.2. External Non-invasive VNS Device
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Epilepsy
    • 11.5.2. Depression
    • 11.5.3. Migraine
    • 11.5.4. Others
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Centers
    • 11.6.4. Academic & Research Institutes
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Vagus Nerve Stimulation Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Implantable VNS Device
    • 12.4.2. External Non-invasive VNS Device
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Epilepsy
    • 12.5.2. Depression
    • 12.5.3. Migraine
    • 12.5.4. Others
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Ambulatory Surgical Centers
    • 12.6.4. Academic & Research Institutes
    • 12.6.5. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Soterix Medical Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. LivaNova PLC
    • 13.3.3. SetPoint Medical
    • 13.3.4. Vagutism
    • 13.3.5. tVNS Technologies GmbH
    • 13.3.6. electroCore, Inc.
    • 13.3.7. Adriakaim, Inc.
    • 13.3.8. MicroTransponder Inc.
    • 13.3.9. Parasym, Ltd.
    • 13.3.10. Pulsetto
    • 13.3.11. Teliatry, Inc.
    • 13.3.12. biolitec(R) Holding GmbH & Co KG
    • 13.3.13. AURIMOD GMBH
    • 13.3.14. Evren Technologies, Inc.
    • 13.3.15. NeurGear
    • 13.3.16. Hoolest
    • 13.3.17. Neuvana
    • 13.3.18. BioSelf Technology Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations